Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...

Kymera Therapeutics (KYMR) stays a Strong Buy on KT-621 Phase 1b AD results, FDA Fast Track, and $1.6B cash runway—click to ...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...

Johnson & Johnson’s immunology drug Tremfya is looking to challenge AbbVie’s dominance in 2026, securing the top spot as the ...

Two of Sanofi’s lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic ...

Regeneron Pharmaceuticals and Sanofi have won expanded European regulatory approval of their blockbuster anti-inflammatory drug Dupixent for younger patients with the inflammatory skin condition ...

The American Academy of Dermatology issued its first-ever guidance for the medical management of pediatric eczema, a skin ...

Super Bowl LX is over and the Seattle Seahawks have triumphed over the New England Patriots. While their epic battle was the star of the night, the commercials that surrounded the game were just as ...

For six-year-old Jesse Callaghan of Sylvania, the battle began at just three months old. His mother, Kaitlin Woods, describes ...

Ad-Free Prime Video Just Got More Expensive, Lower Tier Drops Big Perk Starting today, the newly rebranded Prime Video Ultra will cost $2 more per month, while 4K video support will be stripped from ...